Ligand-dependent corepressor (LCoR) recruitment by Krüppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene

Journal of Biological Chemistry

Volumn 287, Issue 12, 2012, Pages 8662-8674

  Calderon, Mario R ^a   Verway, Mark ^a   An, Beum Soo ^a   DiFeo, Analisa ^b   Bismar, Tarek A ^c   Ann, David K ^d   Martignetti, John A ^b   Shalom Barak, Tali ^e   White, John H ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEINS; C-TERMINAL DOMAINS; CANCER CELLS; COFACTORS; COREPRESSOR COMPLEXES; COREPRESSORS; CYCLIN-DEPENDENT KINASE INHIBITORS; E-CADHERINS; GENE TRANSCRIPTIONS; GENES ENCODING; HDAC INHIBITORS; HISTONE DEACETYLASES; MULTIPLE CLASS; N-TERMINALS; PROSTATE CANCERS; PROSTATE CARCINOMA; TARGET GENES; TRANSACTIVATION; TRANSCRIPTIONAL REPRESSION; TUMOR SUPPRESSORS; YEAST TWO HYBRID;

CELLS; CYTOLOGY; LIGANDS; TRANSCRIPTION; TRANSCRIPTION FACTORS; UROLOGY;

GENE EXPRESSION REGULATION;

COREPRESSOR PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; KRUPPEL LIKE FACTOR 6; LIGAND DEPENDENT COREPRESSOR; TRICHOSTATIN A; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CDKN1A GENE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE ADENOCARCINOMA; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; TRANSCRIPTION REGULATION;

CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS;

EID: 84863416415     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.311605     Document Type: Article

References (50)

1. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer. The next generation. Cell 144, 646-674
2. Shen, M. M., and Abate-Shen, C. (2010) Molecular genetics of prostate cancer. New prospects for old challenges. Genes Dev. 24, 1967-2000
3. DiFeo, A., Martignetti, J. A., and Narla, G. (2009) The role of KLF6 and its splice variants in cancer therapy. Drug Resist. Updat. 12, 1-7
4. Narla, G., Heath, K. E., Reeves, H. L., Li, D., Giono, L. E., Kimmelman, A. C., Glucksman, M. J., Narla, J., Eng, F. J., Chan, A. M., Ferrari, A. C., Martignetti, J. A., and Friedman, S. L. (2001) KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294, 2563-2566 (Pubitemid 34027299)
5. Benzeno, S., Narla, G., Allina, J., Cheng, G. Z., Reeves, H. L., Banck, M. S., Odin, J. A., Diehl, J. A., Germain, D., and Friedman, S. L. (2004) Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res. 64, 3885-3891 (Pubitemid 38697300)
6. Ito, G., Uchiyama, M., Kondo, M., Mori, S., Usami, N., Maeda, O., Kawabe, T., Hasegawa, Y., Shimokata, K., and Sekido, Y. (2004) Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res. 64, 3838-3843 (Pubitemid 38697293)
7. DiFeo, A., Narla, G., Camacho-Vanegas, O., Nishio, H., Rose, S. L., Buller, R. E., Friedman, S. L., Walsh, M. J., and Martignetti, J. A. (2006) E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. Oncogene 25, 6026-6031 (Pubitemid 44477296)
8. Narla, G., Kremer-Tal, S., Matsumoto, N., Zhao, X., Yao, S., Kelley, K., Tarocchi, M., and Friedman, S. L. (2007) In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma. Oncogene 26, 4428-4434 (Pubitemid 47014461)
9. Li, D., Yea, S., Dolios, G., Martignetti, J. A., Narla, G., Wang, R., Walsh, M. J., and Friedman, S. L. (2005) Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation. Cancer Res. 65, 9216-9225 (Pubitemid 41507987)
10. Liu, S., Bishop, W. R., and Liu, M. (2003) Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist. Updat. 6, 183-195 (Pubitemid 37129918)
11. Yang, Z. Y., Perkins, N. D., Ohno, T., Nabel, E. G., and Nabel, G. J. (1995) The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1, 1052-1056
12. Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle 7, 1828-1835
13. Sugibayashi, R., Kiguchi, Y., Shimizu, T., Suzuki, T., Hamada, H., and Takeda, K. (2002) Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines. Anticancer Res. 22, 713-719 (Pubitemid 34475219)
14. CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1. Cancer Res. 70, 9916-9926
15. Lu, S., Tsai, S. Y., and Tsai, M. J. (1999) Molecular mechanisms of androgen- independent growth of human prostate cancer LNCaP-AI cells. Endocrinology 140, 5054-5059
16. Baretton, G. B., Klenk, U., Diebold, J., Schmeller, N., and Löhrs, U. (1999) Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy. Prognostic significance of p21WAF1/CIP1 expression. Br. J. Cancer 80, 546-555 (Pubitemid 29213212)
17. waf1/cip1 protein in prostate cancer. Prostate 39, 8-15
18. Fizazi, K., Martinez, L. A., Sikes, C. R., Johnston, D. A., Stephens, L. C., McDonnell, T. J., Logothetis, C. J., Trapman, J., Pisters, L. L., Ordoñez, N. G., Troncoso, P., and Navone, N. M. (2002) The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer. Clin. Cancer Res. 8, 775-781 (Pubitemid 34742107)
19. Abbas, T., and Dutta, A. (2009) p21 in cancer. Intricate networks and multiple activities. Nat. Rev. Cancer 9, 400-414
20. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumor progression. Nat. Rev. Cancer 2, 442-454
21. Fernandes, I., Bastien, Y., Wai, T., Nygard, K., Lin, R., Cormier, O., Lee, H. S., Eng, F., Bertos, N. R., Pelletier, N., Mader, S., Han, V. K., Yang, X. J., and White, J. H. (2003) Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol. Cell 11, 139-150 (Pubitemid 36126597)
22. Palijan, A., Fernandes, I., Verway, M., Kourelis, M., Bastien, Y., Tavera-Mendoza, L. E., Sacheli, A., Bourdeau, V., Mader, S., and White, J. H. (2009) Ligand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression. J. Biol. Chem. 284, 30275-30287
23. Palijan, A., Fernandes, I., Bastien, Y., Tang, L., Verway, M., Kourelis, M., Tavera-Mendoza, L. E., Li, Z., Bourdeau, V., Mader, S., Yang, X. J., and White, J. H. (2009) Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR. J. Biol. Chem. 284, 30264-30274
24. Asim, M., Hafeez, B. B., Siddiqui, I. A., Gerlach, C., Patz, M., Mukhtar, H., and Baniahmad, A. (2011) Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase. J. Biol. Chem. 286, 37108-37117
25. Shi, Y., Sawada, J., Sui, G., Affar el, B., Whetstine, J. R., Lan, F., Ogawa, H., Luke, M. P., and Nakatani, Y. (2003) Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422, 735-738 (Pubitemid 36514114)
26. Wang, J., Scully, K., Zhu, X., Cai, L., Zhang, J., Prefontaine, G. G., Krones, A., Ohgi, K. A., Zhu, P., Garcia-Bassets, I., Liu, F., Taylor, H., Lozach, J., Jayes, F. L., Korach, K. S., Glass, C. K., Fu, X. D., and Rosenfeld, M. G. (2007) Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446, 882-887 (Pubitemid 46633160)
27. Kaipparettu, B. A., Malik, S., Konduri, S. D., Liu, W., Rokavec, M., van der Kuip, H., Hoppe, R., Hammerich-Hille, S., Fritz, P., Schroth, W., Abele, I., Das, G. M., Oesterreich, S., and Brauch, H. (2008) Estrogen-mediated down-regulation of CD24 in breast cancer cells. Int J Cancer 123, 66-72 (Pubitemid 351705193)
28. Cavaillès, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P. J., and Parker, M. G. (1995) Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751
29. Treuter, E., Albrektsen, T., Johansson, L., Leers, J., and Gustafsson, J. A. (1998) A regulatory role for RIP140 in nuclear receptor activation. Mol. Endocrinol. 12, 864-881 (Pubitemid 30659060)
30. Lee, Y. K., Thomas, S. N., Yang, A. J., and Ann, D. K. (2007) Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells. J. Biol. Chem. 282, 1595-1606 (Pubitemid 47076713)
31. Tavera-Mendoza, L. E., Quach, T. D., Dabbas, B., Hudon, J., Liao, X., Palijan, A., Gleason, J. L., and White, J. H. (2008) Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist. Proc. Natl. Acad. Sci. U.S.A. 105, 8250-8255 (Pubitemid 351904740)
32. Devlin, A. M., Bottiglieri, T., Domann, F. E., and Lentz, S. R. (2005) Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J. Biol. Chem. 280, 25506-25511 (Pubitemid 40962255)
33. waf1/cip1 promoter. Oncogene 29, 6027-6039
34. Gartel, A. L., and Tyner, A. L. (1999) Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp. Cell Res. 246, 280-289 (Pubitemid 29393989)
35. Batsché, E., Muchardt, C., Behrens, J., Hurst, H. C., and Crémisi, C. (1998) RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol. Cell. Biol. 18, 3647-3658
36. Sowa, Y., Orita, T., Minamikawa, S., Nakano, K., Mizuno, T., Nomura, H., and Sakai, T. (1997) Histone deacetylase inhibitor activates the WAF1/ Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 241, 142-150 (Pubitemid 28033553)
37. WAF1 expression and gene-associated histone acetylation. Proc. Natl. Acad. Sci. U.S.A. 97, 10014-10019
38. Peinado, H., Ballestar, E., Esteller, M., and Cano, A. (2004) Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)-HDAC2 complex. Mol. Cell. Biol. 24, 306-319 (Pubitemid 38010056)
39. Huang, X., Li, X., and Guo, B. (2008) KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3. J. Biol. Chem. 283, 29795-29801
40. Guo, H., Lin, Y., Zhang, H., Liu, J., Zhang, N., Li, Y., Kong, D., Tang, Q., and Ma, D. (2007) Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells. BMC Mol. Biol. 8, 110
41. Das, A., Fernandez-Zapico, M. E., Cao, S., Yao, J., Fiorucci, S., Hebbel, R. P., Urrutia, R., and Shah, V. H. (2006) Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration. J. Biol. Chem. 281, 39105-39113 (Pubitemid 46041869)
42. Kojima, S., Hayashi, S., Shimokado, K., Suzuki, Y., Shimada, J., Crippa, M. P., and Friedman, S. L. (2000) Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-β1 in vascular endothelial cells. Blood 95, 1309-1316 (Pubitemid 30099840)
43. Saramäki, A., Diermeier, S., Kellner, R., Laitinen, H., Vaïsänen, S., and Carlberg, C. (2009) Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1α,25-dihydroxyvitamin D3. J. Biol. Chem. 284, 8073-8082
44. Foster, C. T., Dovey, O. M., Lezina, L., Luo, J. L., Gant, T. W., Barlev, N., Bradley, A., and Cowley, S. M. (2010) Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability. Mol. Cell. Biol. 30, 4851-4863
45. Li, S., Chen, P. L., Subramanian, T., Chinnadurai, G., Tomlinson, G., Osborne, C. K., Sharp, Z. D., and Lee, W. H. (1999) Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J. Biol. Chem. 274, 11334-11338
46. Pelzer, A. E., Bektic, J., Haag, P., Berger, A. P., Pycha, A., Schäfer, G., Rogatsch, H., Horninger, W., Bartsch, G., and Klocker, H. (2006) The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer. J. Urol. 175, 1517-1522
47. Huff, V. (2011) Wilms' tumors. About tumor suppressor genes, an oncogene and a chameleon gene. Nat. Rev. Cancer 11, 111-121
48. Grooteclaes, M. L., and Frisch, S. M. (2000) Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19, 3823-3828 (Pubitemid 30621190)
49. Graham, T. R., Zhau, H. E., Odero-Marah, V. A., Osunkoya, A. O., Kimbro, K. S., Tighiouart, M., Liu, T., Simons, J. W., and O'Regan, R. M. (2008) Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 68, 2479-2488 (Pubitemid 351521824)
50. Metzger, E., Imhof, A., Patel, D., Kahl, P., Hoffmeyer, K., Friedrichs, N., Müller, J. M., Greschik, H., Kirfel, J., Ji, S., Kunowska, N., Beisenherz-Huss, C., Günther, T., Buettner, R., and Schüle, R. (2010) Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. Nature 464, 792-796